Pediatric Complete Androgen Insensitivity Syndrome (CAIS): Clinical Presentation, Hormonal Profiles, and Gonadal Management

IF 1.9 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM
Elzbieta Marczak, Maria Szarras-Czapnik, Agata Skórka, Kinga Kowalczyk, Gabriela Grochowska, Malgorzata Walewska-Wolf, Barbara Antoniak, Katarzyna Bajszczak, Elżbieta Moszczyńska
{"title":"Pediatric Complete Androgen Insensitivity Syndrome (CAIS): Clinical Presentation, Hormonal Profiles, and Gonadal Management","authors":"Elzbieta Marczak, Maria Szarras-Czapnik, Agata Skórka, Kinga Kowalczyk, Gabriela Grochowska, Malgorzata Walewska-Wolf, Barbara Antoniak, Katarzyna Bajszczak, Elżbieta Moszczyńska","doi":"10.4274/jcrpe.galenos.2025.2025-5-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Complete androgen insensitivity syndrome (CAIS) is caused by mutations in the <i>androgen receptor (AR)</i> gene, leading to androgen resistance. Early recognition is critical for optimal management. To evaluate clinical presentations, hormonal profiles, genetic characteristics, and decisions regarding gonadectomy in pediatric CAIS. Factors influencing gonadectomy, including malignancy risk, gonadal function, and psychological well-being were assessed.</p><p><strong>Methods: </strong>Medical records of 16 children with genetically confirmed CAIS patients, aged 3 days-18 years, diagnosed between 2004 and 2024 at a tertiary referral center were retrospectively reviewed. Clinical, hormonal, genetic, and histological data were analyzed.</p><p><strong>Results: </strong>Twelve patients (75%) were diagnosed prepubertally, most commonly due to inguinal hernia. Familial recurrence occurred in four cases (25%). Novel pathogenic AR variants not previously reported in public databases were identified in three patients. Prepubertal patients with hormone data (n=5) demonstrated Anti-Müllerian hormone>150 pM. Pubertal patients (n=9) had markedly elevated testosterone levels [median at 1361.3 ng/dL, range 367-3460 ng/dL]. Gonadal biopsy was performed in three cases (19%). Gonadal preservation was recommended in 11 children (69%), while five (31%) underwent gonadectomy followed by estrogen replacement therapy.</p><p><strong>Conclusion: </strong>Most CAIS cases in this pediatric cohort were detected early through inguinal hernia or family screening. Delayed gonadectomy allowed spontaneous pubertal development and feminization. While gonadectomy results in lifelong hormone dependence and may raise identity-related concerns, surveillance-based gonadal preservation appears safe during childhood. The identification of novel <i>AR</i> variants expands the mutational spectrum of CAIS and highlights the need for multicenter registries and improved biomarkers to optimize individualized care.</p>","PeriodicalId":48805,"journal":{"name":"Journal of Clinical Research in Pediatric Endocrinology","volume":" ","pages":"273-281"},"PeriodicalIF":1.9000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13325819/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Research in Pediatric Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4274/jcrpe.galenos.2025.2025-5-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Complete androgen insensitivity syndrome (CAIS) is caused by mutations in the androgen receptor (AR) gene, leading to androgen resistance. Early recognition is critical for optimal management. To evaluate clinical presentations, hormonal profiles, genetic characteristics, and decisions regarding gonadectomy in pediatric CAIS. Factors influencing gonadectomy, including malignancy risk, gonadal function, and psychological well-being were assessed.

Methods: Medical records of 16 children with genetically confirmed CAIS patients, aged 3 days-18 years, diagnosed between 2004 and 2024 at a tertiary referral center were retrospectively reviewed. Clinical, hormonal, genetic, and histological data were analyzed.

Results: Twelve patients (75%) were diagnosed prepubertally, most commonly due to inguinal hernia. Familial recurrence occurred in four cases (25%). Novel pathogenic AR variants not previously reported in public databases were identified in three patients. Prepubertal patients with hormone data (n=5) demonstrated Anti-Müllerian hormone>150 pM. Pubertal patients (n=9) had markedly elevated testosterone levels [median at 1361.3 ng/dL, range 367-3460 ng/dL]. Gonadal biopsy was performed in three cases (19%). Gonadal preservation was recommended in 11 children (69%), while five (31%) underwent gonadectomy followed by estrogen replacement therapy.

Conclusion: Most CAIS cases in this pediatric cohort were detected early through inguinal hernia or family screening. Delayed gonadectomy allowed spontaneous pubertal development and feminization. While gonadectomy results in lifelong hormone dependence and may raise identity-related concerns, surveillance-based gonadal preservation appears safe during childhood. The identification of novel AR variants expands the mutational spectrum of CAIS and highlights the need for multicenter registries and improved biomarkers to optimize individualized care.

儿科完全雄激素不敏感综合征(CAIS):临床表现,激素概况和性腺管理。
完全雄激素不敏感综合征(CAIS)是由雄激素受体基因(AR)突变引起的雄激素抵抗。早期识别对管理至关重要。评估儿童CAIS患者的临床表现、激素谱、遗传特征和关于性腺切除术的决定。评估影响性腺切除术的因素,包括恶性肿瘤风险、性腺功能和心理健康。材料和方法:回顾性分析了2004年至2024年间在三级转诊中心诊断的16例经遗传证实的CAIS患儿的医疗记录,年龄3天至18岁。分析临床、激素、遗传和组织学资料。结果:12例(75%)被诊断为青春期前,最常见的原因是腹股沟疝。家族性复发4例(25%)。在三名患者中发现了以前未在公共数据库中报告的新型致病性AR变体。有激素数据的青春期前患者(n=5)显示AMH > 150pm。青春期患者(n=9)睾酮水平明显升高[中位数为1361.3 ng/dl,范围为367-3460 ng/dl]。3例(19%)行性腺活检。11名儿童(69%)建议保留性腺,而5名(31%)接受性腺切除术后雌激素替代治疗。结论:该儿科队列中大多数CAIS病例通过腹股沟疝或家庭筛查早期发现。延迟性腺切除术允许自发的青春期发育和女性化。虽然性腺切除术会导致终生的激素依赖,并可能引起与身份相关的担忧,但在儿童时期,基于监视的性腺保存似乎是安全的。新的AR变异的鉴定扩大了CAIS的突变谱,并强调了多中心注册和改进生物标志物以优化个性化护理的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Research in Pediatric Endocrinology
Journal of Clinical Research in Pediatric Endocrinology ENDOCRINOLOGY & METABOLISM-PEDIATRICS
CiteScore
3.60
自引率
5.30%
发文量
73
审稿时长
20 weeks
期刊介绍: The Journal of Clinical Research in Pediatric Endocrinology (JCRPE) publishes original research articles, reviews, short communications, letters, case reports and other special features related to the field of pediatric endocrinology. JCRPE is published in English by the Turkish Pediatric Endocrinology and Diabetes Society quarterly (March, June, September, December). The target audience is physicians, researchers and other healthcare professionals in all areas of pediatric endocrinology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书